Patents Assigned to MYOS CORP.
  • Spray dried follistatin product
    Patent number: 12251405
    Abstract: Processes for production of a composition containing active follistatin via spray/heat drying of a biological source containing follistatin as well as compositions containing this active follistatin and methods it use increasing muscle mass are provided.
    Type: Grant
    Filed: October 4, 2018
    Date of Patent: March 18, 2025
    Assignee: MYOS CORP.
    Inventors: Maghsoud Dariani, Neerav Padliya, Alexander Tess
  • Methods for alleviating, inhibiting or reversing muscle disuse atrophy in mammals
    Patent number: 12246042
    Abstract: Methods for alleviating one or more symptoms and/or inhibiting muscle disuse atrophy in mammals via administration of compositions of egg powder protein are provided.
    Type: Grant
    Filed: July 1, 2019
    Date of Patent: March 11, 2025
    Assignee: MYOS CORP.
    Inventors: Joseph Mannello, Neerav Padliya, Maghsoud Dariani
  • Methods and compositions for improving quality of life and increasing activity in aging and chronically ill mammals
    Patent number: 11833186
    Abstract: Methods for improving quality of life and/or increasing activity in an aging and/or chronically ill mammal via administration of a composition of egg powder protein are provided.
    Type: Grant
    Filed: January 29, 2020
    Date of Patent: December 5, 2023
    Assignee: MYOS CORP.
    Inventors: Joseph Mannello, Maghsoud Dariani, Neerav D. Padliya
  • Avian follistatin product
    Patent number: 11433104
    Abstract: Described herein are avian follistatin products, and methods for producing such products, in which such products are effective for a variety of conditions, including increasing muscle mass. Avian follistatin products described herein are packaged as dietary supplements or nutritional supplements are useful in muscle regeneration.
    Type: Grant
    Filed: October 3, 2017
    Date of Patent: September 6, 2022
    Assignee: MYOS CORP.
    Inventors: Richard Paul Green, III, Richard Paul Green, Sr., Carlon M. Colker
  • Methods and compositions for improving skeletal muscle protein fractional synthetic rate
    Patent number: 11318171
    Abstract: Methods and egg yolk powder containing compositions for improving skeletal muscle protein fractional synthetic rate (FSR) in mammals and inhibiting or reversing sarcopenia are provided.
    Type: Grant
    Filed: May 18, 2020
    Date of Patent: May 3, 2022
    Assignee: MYOS CORP.
    Inventors: Joseph Mannello, Neerav D. Padliya, Maghsoud Dariani